Gender transition hormone therapy may increase cardiovascular risk: Study
A
new study revealed that patients receiving hormone
therapy as a part of their gender-transition treatment
are at an elevated risk of developing cardiovascular
diseases, including strokes, heart attacks and blood
clots.
The
study was published in 'Circulation: Journal of the American Heart
Association'.
The
results are based on an analysis of medical records of 3,875 Dutch
individuals who received hormone treatment between 1972and 2015 as
part of their gender transition.
"In
light of our results, we urge both physicians and transgender
individuals to be aware of this increased cardiovascular risk,"
said study author Nienke Nota.
"It
may be helpful to reduce risk factors by stopping smoking,
exercising, eating a healthy diet and losing weight, if needed before
starting therapy, and clinicians should continue to evaluate patients
on an ongoing basis thereafter," Nota added.
Past
research has shown that hormone therapy increases cardiovascular risk
among people receiving it to alleviate symptoms of menopause, yet
research evidence remains scarce on the effects of hormone treatment
in people undergoing gender transition.
Even
though such individuals tend to be younger than menopausal patients
receiving hormone-replacement therapy, transgender people may have
more psychosocial stressors and other factors that increase
cardiovascular risk, the researchers stated. Read
More
Article
Source -> Business
Standard
Comments
Post a Comment